Abstract
Purpose
To report the clinical spectrum of Vogt-Koyanagi-Harada (VKH) disease in a tertiary care center in South India.
Methods
Medical records of patients diagnosed with VKH disease who presented between January 1995 and December 2003, with a minimum follow-up of one year were reviewed.
Results
Of the 45 patients, 38 (84.44%) were female. The median age was 37 years (SD ± 14.23) and median duration of symptoms was 30 days (range 1 day to 1 year). 75.5% (34/45) presented with bilateral anterior uveitis. Posterior segment presentation included disc edema (31/45), bilateral serous retinal detachments (26/45), vitritis (17/45) and sunset glow (8/45). Extra ocular manifestations were seen in only 4/45 (tinnitus: 2, meningismus: 1, poliosis: 1). 97.7% (44/45) received oral Prednisolone (1 mg/kg body weight) for a median duration of 14 months. 69% (31/45) received additional three pulses of intravenous methylprednisolone and 22% (10/45) received a single infusion of intravenous Cyclophosphamide. One patient received intravitreal triamcinolone injection 53.33% (24/45) were treated with additional immunosupressants. At the first visit, best corrected visual acuity (BCVA) was ≥20/40 in 23 eyes (25.55%) and ≤20/400 in 37 eyes (41.11%). At one year, 61 eyes (67.77%) achieved BCVA of ≥20/40 while 12 eyes (13.33%) had BCVA ≤20/400. Complicated cataract, glaucoma and macular scar were the major complications encountered.
Conclusions
Majority of patients with ocular VKH presented with anterior uveitis and serous retinal detachments and disc edema. Extra-ocular signs are rare in our patients. Visual prognosis is good with treatment with adequate long-term corticosteroids and immunosuppressive agents.
Similar content being viewed by others
References
Read RW (2002) Vogt-Koyanagi-Harada disease. Ophthalmol Clin North Am 15(3):333–341
Davis JL, Mittal KK, Freidlin V, Mellow SR, Optican DC, Palestine AG et al (1990) HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. Ophthalmology 97(9):1137–1142
Martinez JA, Lopez PF, Sternberg P Jr, Aaberg TM, Lambert HM, Capone A Jr et al (1992) Vogt-Koyanagi-Harada syndrome in patients with Cherokee Indian ancestry. Am J Ophthalmol 114(5):615–620
Mondkar SV, Biswas J, Ganesh SK (2000) Analysis of 87 cases with Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 44(3):296–301
Moorthy RS, Inomata MS, Rao NA (1995) Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 39(4):265–292
Beniz J, Forster DJ, Lean JS, Smith RE, Rao NA (1991) Variations in clinical features of the Vogt-Koyanagi-Harada syndrome. Retina 11(3):275–280
Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L et al (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131(5):647–652
Forster DJ, Cano MR, Green RL, Rao NA (1990) Echographic features of the Vogt-Koyanagi-Harada syndrome. Arch Ophthalmol 108(10):1421–1426
Sheu SJ, Kou HK, Chen JF (2003) Prognostic factors for Vogt-Koyanagi-harada disease. J Clin Med Assoc 66(3):148–154
Kou IC, Rechdouni A, Rao NA, Johnston RH, Margolis TP, Cunningham Et Jr (2000) Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease. Ophthalmology 107(9):1721–1728
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Murthy, S.I., Moreker, M.R., Sangwan, V.S. et al. The spectrum of Vogt-Koyanagi-Harada disease in South India. Int Ophthalmol 27, 131–136 (2007). https://doi.org/10.1007/s10792-007-9046-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-007-9046-9